Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period
T. Terada et al., Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period, VIRCHOWS AR, 435(6), 1999, pp. 606-611
Citations number
27
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
We report an autopsy case of mixed ductal-endocrine carcinoma of the pancre
as presenting as gastrinoma with Zollinger-Ellison syndrome. A 38-year-old
Japanese male was found to have Zollinger-Ellison syndrome and pancreatic g
astrinoma, and gastrectomy and resection of the pancreatic turner were perf
ormed. However, hypergastrinemia persisted, and the patient died of dissemi
nated carcinomatosis at 62 years of age, 24 years after the onset of Zollin
ger-Ellison syndrome. At autopsy, the main tumor was present in the residua
l pancreas, and metastases were noted in many organs. In the pancreas and o
ther organs, ductal and endocrine carcinoma areas were mixed and there was
a gradual transition between the two. No acinar differentiation was noted.
The ductal elements were positive for mucins and carcinoembryonic antigen b
ut negative for neuroendocrine markers, while endocrine elements were posit
ive for chromogranin A and synaptophysin and to a lesser extent for gastrin
, but negative for mucins and carcinoembryonic antigen. The ductal elements
comprised about 30% of the tumor cells, and endocrine elements 70%. Accord
ing to the revised World Health Organization classification, our case was d
iagnosed as mixed ductal-endocrine carcinoma. Our case is rare because the
tumor manifested as gastrinoma with Zollinger-Ellison syndrome and the pati
ent survived for 24 years. To the best of our knowledge, no such case has b
een reported. Our case suggests that pancreatic endocrine tumors may evolve
into mixed ductal-endocrine carcinomas.